Table 1

Demographic and clinical data of included children with abdominal NB

VariablesMissingOverall
(N=74)
Surgical riskP value
No (n=19)Yes (n=55)
Age, Mean±SD04.0 (2.7)4.2 (3.8)4.0 (2.2)0.774
Sex, n (%)1.000
 Female39 (52.7)10 (52.6)29 (52.7)
 Male035 (47.3)9 (47.4)26 (47.3)
Mode, n (%)<0.001
 Yes028 (37.8)18 (94.7)10 (18.2)
 No46 (62.2)1 (5.3)45 (81.8)
Metastasis, n (%)
 No037 (50.0)19 (100.0)18 (32.7)
 Yes37 (50.0)0 (0.0)37 (67.3)
NSE, n (%)148.0 (66.1)28.3 (31.3)54.4 (73.1)0.038
 I011 (14.9)10 (52.6)1 (1.8)
 II30 (40.5)6 (31.6)24 (43.6)
INSS stage, n (%)
 III8 (10.8)0 (0.0)8 (14.5)
 IV25 (33.8)3 (15.8)22 (40.0)
MCYN, n (%)0.563
 Amplification2149 (92.5)14 (100.0)35 (89.7)
 No amplification4 (7.5)0 (0.0)4 (10.3)
11q-23, n (%)0.282
 No absence2149 (92.5)12 (85.7)37 (94.9)
 Absence4 (7.5)2 (14.3)2 (5.1)
SRD-1p36, n (%)1
 No absence2140 (75.5)11 (78.6)29 (74.4)
 Absence13 (24.5)3 (21.4)10 (25.6)
Ki67, Mean±SD10.2 (0.3)0.1 (0.2)0.2 (0.3)0.055
NB surrounding peripheral large vessels, n (%)< 0.001
 No039 (52.7)19 (100.0)20 (36.4)
 Yes35 (47.3)0 (0.0)35 (63.6)
NB extending into intervertebral space, n (%)0.18
 No067 (90.5)19 (100.0)48 (87.3)
 Yes7 (9.5)0 (0.0)7 (12.7)
NB invading kidney, n (%)0.017
 No061 (82.4)19 (100.0)42 (76.4)
 Yes13 (17.6)0 (0.0)13 (23.6)
NB crossing the midline, n (%)0.003
 No052 (70.3)19 (100.0)33 (60.0)
 Yes22 (29.7)0 (0.0)22 (40.0)
  • INSS, International Neuroblastoma Staging System; MYCN, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog; NB, neuroblastoma; NSE, neuron-specific enolase; SD, standard deviation.